ArticleDiabetes technology & therapeutics2022

Use of an Ultrarapid Acting Insulin Analog with Control-IQ: A Case Report.

Melissa J Schoelwer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.